Inato

Diversity
#Clinical trial design #Clinical trials #Diversity #Inato #Inclusivity #Investment #Oncology

$20 million in new funding to make clinical trials more inclusive

Clinical trial technology platform Inato, based in Paris, France, has closed a $20 million Series A funding from investors including Cathay Innovation, Obvious Ventures, La Maison and Top Harvest Capital. With the new funding, Inato will advance its diversity product offering to meet the new FDA… Read More

#Business & Investment #News #Start-up Zone